Erlotinib Unknown Status Phase 2 Trials for Brain and Central Nervous System Tumors Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00054496Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme